Progressive hemodialysis: Is it the future?

Seminars in Dialysis

Volumn 29, Issue 3, 2016, Pages 179-183

  Libetta, Carmelo ^a,b   Nissani, Peni ^b   dal Canton, Antonio ^a,b  

^a FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CHRONIC KIDNEY FAILURE; CONSERVATIVE TREATMENT; HEMODIALYSIS; HUMAN; KIDNEY; PATHOPHYSIOLOGY; PERITONEAL DIALYSIS;

CONSERVATIVE TREATMENT; HUMANS; KIDNEY; KIDNEY FAILURE, CHRONIC; PERITONEAL DIALYSIS; RENAL DIALYSIS;

EID: 84946882372     PISSN: 08940959     EISSN: 1525139X     Source Type: Journal    
DOI: 10.1111/sdi.12455     Document Type: Editorial

References (60)

1. Scribner BH, Cole JJ, Ahmad S, Blagg CR: Why thrice weekly dialysis? Hemodial Int 8(2):188-192, 2004
2. Lowrie EG, Laird NM, Parker TF, Sargent JA: Effect of the hemodialysis prescription of patient morbidity: report from the National Cooperative Dialysis Study (NCDS). N Engl J Med 305 (20):1176-1181, 1981
3. Eknoyan G, Beck GJ, Cheung AK, Daugirdas JT, Greene T, Kusek JW, et al.; Hemodialysis (HEMO) Study Group: Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med 347(25):2010-2019, 2002
4. Rhee CM, Unruh M, Chen J, Kovesdy CP, Zager P, Kalantar-Zadeh K: Infrequent dialysis: a new paradigm for hemodialysis initiation. Semin Dial 26(6):720-727, 2013
5. Canada-USA (CANUSA) Peritoneal Dialysis Study Group: Adequacy of dialysis and nutrition in continuous peritoneal dialysis: association with clinical outcomes. J Am Soc Nephrol 7(2):198-207, 1996
6. Bargman JM, Thorpe KE, Churchill DN; CANUSA Peritoneal Dialysis Study Group: Relative contribution of residual renal function and peritoneal clearance to adequacy of dialysis: a reanalysis of the CANUSA study. J Am Soc Nephrol 12(10):2158-2162, 2001
7. Shemin D, Bostom AG, Laliberty P, Dworkin LD: Residual renal function and mortality risk in hemodialysis patients. Am J Kidney Dis, 38(1):85-90, 2001
8. Termorshuizen F, Korevaar JC, Dekker FW, van Manen JG, Boeschoten EW, Krediet RT; NECOSAD Study Group: The relative importance of residual renal function compared with peritoneal clearance for patient survival and quality of life: an analysis of the Netherlands Cooperative Study on the Adequacy of Dialysis (NECOSAD)-2: Am J Kidney Dis 41(6):1293-1302, 2003
9. Termorshuizen F, Dekker FW, van Manen JG, Korevaar JC, Boeschoten EW, Krediet RT; NECOSAD Study Group: Relative contribution of residual renal function and different measures of adequacy to survival in hemodialysis patients: an analysis of the Netherlands Cooperative Study on the Adequacy of Dialysis (NECOSAD)-2. J Am Soc Nephrol 15(4):1061-1070, 2004
10. van der Wal WM, Noordzij M, Dekker FW, Boeschoten EW, Krediet RT, Korevaar JC, et al.; Netherlands Cooperative Study on the Adequacy of Dialysis Study Group (NECOSAD): Full loss of residual renal function causes higher mortality in dialysis patients; findings from a marginal structural model. Nephrol Dial Transplant 26 (9):2978-2983, 2011
11. Vilar E, Wellsted D, Chandna SM, Greenwood RN, Farrington K: Residual renal function improves outcome in incremental haemodialysis despite reduced dialysis dose. Nephrol Dial Transplant 24(8):2502-2510, 2009
12. Brener ZZ, Thijssen S, Kotanko P, Kuhlmann MK, Bergman M, Winchester JF, et al.: The impact of residual renal function on hospitalization and mortality in incident hemodialysis patients. Blood Purif 31(4):243-251, 2014
13. Shafi T, Jaar BG, Plantinga LC, Fink NE, Sadler JH, Parekh RS, et al.: Association of residual urine output with mortality, quality of life, and inflammation in incident hemodialysis patients: the Choices for Healthy Outcomes in Caring for End-Stage Renal Disease (CHOICE) study. Am J Kidney Dis 56(2):348-358, 2010
14. Cheung AK, Rocco MV, Yan G, Leypoldt JK, Levin NW, Greene T, et al.: Serum beta-2 microglobulin levels predict mortality in dialysis patients: results of the HEMO study. J Am Soc Nephrol 17(2):546-555, 2006
15. Chertow GM, Levin NW, Beck GJ, Depner TA, Eggers PW, Gassman JJ, et al.; FHN Trial Group: In-center hemodialysis six times per week versus three times per week. N Engl J Med 363(24):2287-2300, 2010
16. Daugirdas JT, Greene T, Rocco MV, Kaysen GA, Depner TA, Levin NW, et al.; FHN Trial Group: Effect of frequent hemodialysis on residual kidney function. Kidney Int 83(5):949-958, 2013
17. Chazot C, Charra B, Vo Van C, Jean G, Vanel T, Calemard E, et al.: The Janus-faced aspect of ‘dry weight’. Nephrol Dial Transplant 14 (1):121-124, 1999
18. Kalantar-Zadeh K, Unruh M, Zager PG, Kovesdy CP, Bargman JM, Chen J, et al.: Twice-weekly and incremental hemodialysis treatment for initiation of kidney replacement therapy. Am J Kidney Dis 64 (2):181-186, 2014
19. Hemodialysis Adequacy 2006 Work Group: Clinical practice guidelines for hemodialysis adequacy, update 2006. Am J Kidney Dis 48 (Suppl. 1):S2-S90, 2006
20. Hanson JA, Hulbert-Shearon TE, Ojo AO, Port FK, Wolfe RA, Agodoa LY, et al.: Prescription of twice-weekly hemodialysis in the USA. Am J Nephrol 19(6):625-633, 1999
21. Fernández-Lucas M, Teruel-Briones JL, Gomis-Couto A, Villacorta-Pérez J, Quereda-Rodríguez-Navarro C: Maintaining residual renal function in patients on haemodialysis: 5-year experience using a progressively increasing dialysis regimen. Rev Nefrol 32(6):767-776, 2012
22. Teruel-Briones JL, Fernández-Lucas M, Rivera-Gorrin M, Ruiz-Roso G, D_ıaz-Domínguez M, Rodríguez-Mendiola N, et al.: Progression of residual renal function with an increase in dialysis: haemodialysis versus peritoneal dialysis. Rev Nefrol 33(5):640-649, 2013
23. Lin YF, Huang JW, Wu MS, Chu TS, Lin SL, Chen YM, et al.: Comparison of residual renal function in patients undergoing twiceweekly versus three-times-weekly haemodialysis. Nephrology 14(1):59-64, 2009
24. Lin X, Yan Y, Ni Z, Gu L, Zhu M, Dai H, et al.: Clinical outcome of twice-weekly hemodialysis patients in Shanghai. Blood Purif 33(1-3):66-72, 2012
25. Zhang M, Wang M, Li H, Yu P, Yuan L, Hao C, et al.: Association of initial twice-weekly hemodialysis treatment with preservation of residual kidney function in ESRD patients. Am J Nephrol 40(2):140-150, 2014
26. Panaput T, Thinkhamrop B, Domrongkitchaiporn S, Sirivongs D, Praderm L, Anukulanantachai J, et al.: Dialysis dose and risk factors for death among ESRD patients treated with twice-weekly hemodialysis: a prospective cohort study. Blood Purif 38(3-4):253-262, 2014
27. Supasyndh O, Satirapoj B, Seenamngoen S, Yongsiri S, Choovichian P, Vanichakarn S: Nutritional status of twice and thrice-weekly hemodialysis patients with weekly Kt/V > 3.6. J Med Assoc Thai 92 (5):624-631, 2009
28. Stankuviene A, Ziginskiene E, Kuzminskis V, Bumblyte IA: Impact of hemodialysis dose and frequency on survival of patients on chronic hemodialysis in lithuania during 1998-2005. Medicina (Kaunas) 46 (8):516-521, 2010
29. Elamin S, Abu-Aisha H: Reaching target hemoglobin level and having a functioning arteriovenous fistula significantly improve one year survival in twice weekly hemodialysis. Arab J Nephrol Transplant 5(2):81-86, 2012
30. Mitch WE, Sapir DG: Evaluation of reduced dialysis frequency using nutritional therapy. Kidney Int 20(1):122-126, 1981
31. Morelli E, Baldi R, Barsotti G, Ciardella F, Cupisti A, Dani L, et al.: Combined therapy for selected chronic uremic patients: infrequent hemodialysis and nutritional management. Nephron 47(3):161-166, 1987
32. Locatelli F, Andrulli S, Pontoriero G, Di Filippo S, Bigi MC: Supplemented low-protein diet and once-weekly hemodialysis. Am J Kidney Dis 24:192-204, 1994
33. Cardelli R, D’Amicone M, Manzione A, Gurioli L, Grott G, Biselli L, et al.: Weekly dialysis integrated with low-protein diet and essential amino acids. Minerva Urol Nefrol 43(3):211-216, 1991
34. Caria S, Cupisti A, Sau G, Bolasco P: The incremental treatment of ESRD: a low-protein diet combined with weekly hemodialysis may be beneficial for selected patients. BMC Nephrol 15:172-181, 2014
35. Libetta C, Esposito P, Dal Canton A: Once-weekly hemodialysis: a single-center experience. Am J Kidney Dis 65(2):343, 2015
36. Keshaviah PR, Emerson PF, Nolph KD: Timely initiation of dialysis: a urea kinetic approach. Am J Kidney Dis 33(2):344-348, 1999
37. Vilar E, Farrington K: Emerging importance of residual renal function in end-stage renal failure. Semin Dial 24(5):487-494, 2011
38. Bonomini V, Vangelista A, Stefoni S: Early dialysis in renal substitutive programs. Kidney Int Suppl 8:S112-S116, 1978
39. Bonomini V, Feletti C, Scolari MP, Stefoni S: Benefits of early initiation of dialysis. Kidney Int Suppl 17:S57-S59, 1985
40. Fink JC, Burdick RA, Kurth SJ, Blahut SA, Armistead NC, Turner MS, et al.: Significance of serum creatinine values in new end-stage renal disease patients. Am J Kidney Dis 34(4):694-701, 1999
41. Traynor JP, Simpson K, Geddes CC, Deighan CJ, Fox JG: Early initiation of dialysis fails to prolong survival in patients with end-stage renal failure. J Am Soc Nephrol 13(8):2125-2132, 2002
42. Beddhu S, Samore MH, Roberts MS, Stoddard GJ, Ramkumar N, Pappas LM, et al.: Impact of timing of initiation of dialysis on mortality. J Am Soc Nephrol 14(9):2305-2312, 2003
43. Kazmi WH, Gilbertson DT, Obrador GT, Guo H, Pereira BJ, Collins AJ, et al.: Effect of comorbidity on the increased mortality associated with early initiation of dialysis. Am J Kidney Dis 46(5):887-896, 2005
44. Stel VS, Dekker FW, Ansell D, Augustijn H, Casino FG, Collart F, et al.: Residual renal function at the start of dialysis and clinical outcomes. Nephrol Dial Transplant 24(10):3175-3182, 2009
45. Sawhney S, Djurdjev O, Simpson K, Macleod A, Levin A: Survival and dialysis initiation: comparing British Columbia and Scotland registries. Nephrol Dial Transplant 24(10):3186-3192, 2009
46. Cooper BA, Branley P, Bulfone L, Collins JF, Craig JC, Fraenkel MB, et al.: A randomized, controlled trial of early versus late initiation of dialysis. N Engl J Med 363(7):609-619, 2010
47. Mehrotra R, Rivara M, Himmelfarb J: Initiation of dialysis should be timely: neither early nor late. Semin Dial 26(6):644-649, 2013
48. Rosansky SJ, Cancarini G, Clark WF, Eggers P, Germaine M, Glassock R, et al.: Dialysis initiation: what’s the rush? Semin Dial 26 (6):650-657, 2013
49. Metcalfe W, Khan IH, Prescott GJ, Simpson K, MacLeod AM: Can we improve early mortality in patients receiving renal replacement therapy? Kidney Int 57(6):2539-2545, 2000
50. Bradbury BD, Fissell RB, Albert JM, Anthony MS, Critchlow CW, Pisoni RL, et al.: Predictors of early mortality among incident US hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Clin J Am Soc Nephrol 2(1):89-99, 2007
51. Lukowsky LR, Kheifets L, Arah OA, Nissenson AR, Kalantar-Zadeh K: Patterns and predictors of early mortality in incident hemodialysis patients: new insights. Am J Nephrol 35(6):548-558, 2012
52. Gotch FA, Sargent JA: A mechanistic analysis of the National Cooperative Dialysis Study (NCDS). Kidney Int 28(3):526-534, 1985
53. Casino FG, Lopez T: The equivalent renal urea clearance: a new parameter to assess dialysis dose. Nephrol Dial Transplant 11(8):1574-1581, 1996
54. Gotch FA: The current place of urea kinetic modelling with respect to different dialysis modalities. Nephrol Dial Transplant 13(Suppl. 6):10-14, 1998
55. Leypoldt JK, Jaber BL, Zimmerman DL: Predicting treatment dose for novel therapies using urea standard Kt/V. Semin Dial 17(2):142-145, 2004
56. Daugirdas JT, Depner TA, Greene T, Levin NW, Chertow GM, Rocco MV; Frequent Hemodialysis Network Trial Group: Standard Kt/V urea: a method of calculation that includes effects of fluid removal and residual kidney clearance. Kidney Int 77(7):637-644, 2010
57. Casino FG: The grey line of dialysis initiation: as early as possible that is, by the incremental modality. G Ital Nefrol 27(6):574-583, 2010
58. Davenport A: Will incremental hemodialysis preserve residual function and improve patient survival? Semin Dial 28(1):16-19, 2015
59. Wong J, Vilar E, Davenport A, Farrington K: Incremental haemodialysis. Nephrol Dial Transplant 30(10):1639-1648, 2015
60. Vanholder R, Van Biesen W, Lameire N: Is starting hemodialysis on a twice-weekly regimen a valid option? Am J Kidney Dis 64(2):165-167, 2014